Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Jan-Dec:23:15330338241229363.
doi: 10.1177/15330338241229363.

Recent Advances and Challenges in Stereotactic Body Radiotherapy

Atsuto Katano  1 , Masanari Minamitani  2 , Shingo Ohira  2 , Hideomi Yamashita  1
Affiliations
Editorial

Recent Advances and Challenges in Stereotactic Body Radiotherapy

Atsuto Katano et al. Technol Cancer Res Treat. 2024 Jan-Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

    1. Ball D, Mai GT, Vinod S, et al. Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial. Lancet Oncol. Apr 2019;20(4):494-503. doi:10.1016/s1470-2045(18)30896-9 - DOI - PubMed
    1. Sahgal A, Myrehaug SD, Siva S, et al. Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial. Lancet Oncol. Jul 2021;22(7):1023-1033. doi:10.1016/s1470-2045(21)00196-0 - DOI - PubMed
    1. Tree AC, Ostler P, van der Voet H, et al. Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial. Lancet Oncol. Oct 2022;23(10):1308-1320. doi:10.1016/s1470-2045(22)00517-4 - DOI - PubMed
    1. Siddique S, Chow JCL. Artificial intelligence in radiotherapy. Rep Pract Oncol Radiother. Jul. Aug 2020;25(4):656-666. doi:10.1016/j.rpor.2020.03.015 - DOI - PMC - PubMed
    1. Santoro M, Strolin S, Paolani G, et al. Recent applications of artificial intelligence in radiotherapy: where we are and beyond. Appl Sci. 2022;12(7):3223.

Publication types